The transcriptional repressor Snail promotes mammary tumor recurrence-Reference-Cited by-同舟云学术

The transcriptional repressor Snail promotes mammary tumor recurrence

Published:2005-09 Issue:3 Volume:8 Page:197-209
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Moody Susan E.,Perez Denise,Pan Tien-chi,Sarkisian Christopher J.,Portocarrero Carla P.,Sterner Christopher J.,Notorfrancesco Kathleen L.,Cardiff Robert D.,Chodosh Lewis A.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference47 articles.

1. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implication for the epithelial-mesenchymal transition;Bachelder;J. Cell Biol.,2005

2. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer;Baselga;J. Clin. Oncol.,1996

3. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells;Batlle;Nat. Cell Biol.,2000

4. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading;Berger;Cancer Res.,1988

5. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas;Blanco;Oncogene,2002

Cited by 615 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of LOXL3, NES, and SNAI1 in Melanoma Genesis and Progression;Cells;2024-08-29

2. MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma;Best Practice & Research Clinical Endocrinology & Metabolism;2024-08

3. Jianpi‐Tiaoqi decoction inhibits tumour proliferation and lung metastasis in tumour‐bearing mice with triple‐negative breast cancer;Clinical and Experimental Pharmacology and Physiology;2024-06-06

4. Grainyhead-like-2, an epithelial master programmer, promotes interferon induction and suppresses breast cancer recurrence;Molecular Immunology;2024-06

5. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy;Seminars in Cancer Biology;2024-05